Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort Study. - Chang YS; Liu CY; Chen YW; Huang SH; Lin HY; Lin CC; Tsai XC; Tien FM; Cheng CL; Yuan CT; Kuo YY; Ko BS; et al. (Clinical lymphoma, myeloma & leukemia, 2025)